Skip to main content
Caplight Logo









Alleviate

Alleviate

Private
MassachusettsHealthcare & Life Scienceshttps://alleviatetherapy.com/

Last Round

Crowdfunding

Jul 15, 2024

Est. Valuation

$16.22M

Total Funding Raised

$5.59M

Company Overview

Alleviate is a healthcare technology company that designs and produces self-treatment systems for chronic musculoskeletal pain conditions, sold directly to consumers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Sports & Fitness, E-commerce

Business Model

B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

physical therapyat-home recoverymusculoskeletal pain reliefPTD2C healthrehab equipmenthome physical therapyorthopedic supportinjury recoverydigital health appsoft tissue mobilizationtelehealthpain managementwearable recoveryhealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alleviate Comparables

Compare Alleviate with similar companies based on industry and business-model similarity.

Alleviate comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Exakt Health
71%
Hinge Health
62%
Therabody
61%

Alleviate Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJul 15, 2024
CrowdfundingMay 8, 2024
DebtMay 8, 2024
SeedFeb 15, 2023
Pre SeedSep 21, 2022

Key People

Founding team and executive leadership

Alain Tranchemontagne

Chief Executive Officer

Executive Team

Alleviate Investors

Notable investors and investment history

Alleviate investors
InvestorRounds
Oregon Sports AngelsAngel, Pre Seed
Kenston Capital PartnersPre Seed, Debt
Harvard Business School Alumni Angels AssociationAngel, Pre Seed
TCA Venture GroupAngel, Pre Seed
WayfundAngel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 19, 2026

    Monthly visitors increased 33% MoM, reaching 36K.

  • May 8, 2024

    $1.2M raised from StartEngine Crowdfunding

Alleviate Filings

Explore SEC and related filing metadata, where available.

Alleviate filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Alleviate's valuation, stock price, and market status.

Is Alleviate a public or private company?

Alleviate is a private company.

What is the current stock price of Alleviate?

Alleviate is a private company with no public stock price. No recent secondary market data is available.

How much is Alleviate worth (valuation)?

Alleviate's valuation is estimated at $16.2M based on funding round data.

Can I buy Alleviate stock?

Alleviate shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Alleviate's last funding round?

Alleviate's most recent funding round was Crowdfunding on July 15, 2024.

Who are the main investors in Alleviate?

Key investors in Alleviate include Oregon Sports Angels, Kenston Capital Partners, Harvard Business School Alumni Angels Association, TCA Venture Group.

Will Alleviate IPO soon?

No public IPO plans have been announced for Alleviate.

How can I track Alleviate secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Alleviate's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersMassachusetts
Employee Range5
Year Founded2021
Last FundingJul 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?